Navigation Links
Specialty Drug Delivery Firm Integral BioSystems LLC to Participate in Contract Pharma Magazine’s 12th Annual Contracting & Outsourcing Conference & Tabletop Exhibition
Date:7/30/2013

Bedford, Massachusetts (PRWEB) July 30, 2013

Integral BioSystems LLC, led by 20+ year veteran of drug formulation development Shikha P. Barman, Ph.D., will offer potential clients advice on the use of Integral’s novel, platform front-of-the-eye and back-of-the-eye ophthalmic therapeutic delivery systems, OcuSurf™ and EySite™.

Integral BioSystems’ niche is in nano-engineered drug delivery systems aimed at providing solutions to long-held issues in drug products, especially in low drug absorption by target tissues due to cell impermeability and insolubility. In addition to assisting drug companies in developing their dosage forms, Integral scientists are also working on novel solutions to improve the bioavailability of Class II, III and IV compounds.

The Company has developed numerous dosage forms for ophthalmic applications. Integral BioSystems has a translational approach to drug development, customizing delivery systems to achieve the biologically effective objectives of the therapy. Dosage forms are customized to achieve sustained release or targeted, tissue-focused delivery or fast-release/instant delivery, depending upon the desired product attributes.

Once the drug-containing formulations are tested in preclinical models, the Company develops an integrated CMC plan to systematically transition the project to scale up and product development. As part of product development, Integral BioSystems specializes in efficiently developing a dosage form to manufacture and test in Phase I/Phase II first-in-man trials for proof-of-concept. The Company has a network of manufacturers/analytical houses for pharmaceutics that can fast-track the manufacture and release of the sterile dosage form for first-in-man trials.

About Integral BioSystems
Integral BioSystems is a specialty drug delivery contract research organization that offers an integrated, practical approach to formulation development projects for both small molecule and large molecule drug candidates. The Company business model is based on the following corporate objectives: (a) to be a collaborating partner in formulation development/drug product design for start-up and small companies, taking concepts from the laboratory to the clinic, (b) to re-formulate approved drugs for better efficacy and safety profiles, (c) to be a collaborating partner with API synthesis companies to develop generic drug product formats and (d) offer corporate legal services such as contract development/negotiations, patent filings and assessment of IP portfolios.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10980225.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Book Presents Strategies to Improve Patient Outcomes and Control Soaring Specialty Rx Costs
2. SafeToSleep and Brixy Announce Exclusive Program for Brixy Specialty Retailers
3. AJ Palutis and Fred Hait Receive Workers' Compensation Law Specialty Certification
4. Study finds racial and ethnic disparities in usage of specialty services for children with autism
5. ‘2-Hour Patient Acceptance Guarantee’ Program from BioPlus Specialty Pharmacy Rolls Out to Enthusiastic Physician and Patient Response
6. Specialty Technical Publishers (STP) Partners with AECOM to Advance Global EHS Auditing Solutions for Companies
7. BioPlus Specialty Pharmacy Founder and CEO Selected as Finalist in Ernst & Young Florida Entrepreneur of the Year Award
8. U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com
9. Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar
10. Nationally-Recognized Retinal Expert Returns to Gainesville, Joins Retina Specialty Institute
11. Lourdes Specialty Hospital Offers Unique Treatment Option for Medically Complex Patients with Hyperbaric Oxygen Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... science companies, has achieved ISO 17100:2015 certification following a comprehensive audit performed ... the globally recognized standard that establishes guidance for critical processes within translation, ...
(Date:1/23/2017)... ... January 23, 2017 , ... Ultimate Medical Academy today ... to be held March 23-25, 2017 in Tampa, and reminded educators and education ... keynote speakers include Dr. Michelle R. Weise, executive director of the Sandbox Collaborative, ...
(Date:1/23/2017)... ... January 23, 2017 , ... DMG Productions is ... Ed Begley, Jr., scheduled to broadcast Saturday, January 28, 2017 at 5:00pmEST. , ... in 2008 to address the limitations of fatigue monitoring technologies within the mining ...
(Date:1/23/2017)... IL (PRWEB) , ... January 23, 2017 , ... ... first-quality education and high-level training standards for healthcare treatment providers who treat the ... to its Presidents Council. , The Presidents Council consists of the leading ...
(Date:1/23/2017)... ... January 23, 2017 , ... Wooden and plastic balance boards have been around since at ... Kumo Board is the first and only balance board to use a patent-pending ... and rigid at the same time as well as skill-level adjustable for all ages and ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... A new Transparency Market Research report states ... at US$0.53 bn in 2013 and is predicted to touch US$2.38 ... 2014 and 2022. The title of the report is "Non-invasive Prenatal ... Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing (NIPT), also referred to as ...
(Date:1/23/2017)... Longer life expectancy and rising healthcare expenditure in ... medical device technologies. BCC Research reveals in its new report ... region, should see strong growth due to rising government healthcare spending, ... Continue Reading ... ...
(Date:1/23/2017)... January 23, 2017 The global  anxiety disorders and depression ... 2025. The rising incidence of depression worldwide is anticipated to drive the market ... in the declining demand for antidepressants in the recent years. ... ... View Research Logo ...
Breaking Medicine Technology: